#PostConvo #IBDPoll 1️⃣ #MondayNightIBD
🏆🆓#CME👉🏼 http://bit.ly/3DZPnHV
#ORAL Surveillance study: Risk of major adverse cardiovascular event (MACE) was ⬆️ with #Tofacitinib vs TNFi at median of 4 yrs f/up in pts> age 50 + at least 1 CV risk factors in which chronic disease: